Clinical Trial Update: A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

An ongoing Phase 2 clinical trial to evaluate the effects of VHB937 in people with early Alzheimer's disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• VHB937

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Alzheimer's Disease | Phase 2 | Status: RECRUITING